Humana Statistics
Total Valuation
Humana has a market cap or net worth of $33.25 billion. The enterprise value is $42.13 billion.
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Sep 26, 2025 |
Share Statistics
Humana has 120.27 million shares outstanding. The number of shares has decreased by -1.21% in one year.
| Current Share Class | 120.27M |
| Shares Outstanding | 120.27M |
| Shares Change (YoY) | -1.21% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 95.45% |
| Float | 120.05M |
Valuation Ratios
The trailing PE ratio is 21.20 and the forward PE ratio is 18.72. Humana's PEG ratio is 2.42.
| PE Ratio | 21.20 |
| Forward PE | 18.72 |
| PS Ratio | 0.27 |
| Forward PS | 0.25 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | 13.63 |
| P/OCF Ratio | 11.34 |
| PEG Ratio | 2.42 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.49, with an EV/FCF ratio of 17.27.
| EV / Earnings | 26.73 |
| EV / Sales | 0.34 |
| EV / EBITDA | 10.49 |
| EV / EBIT | 11.19 |
| EV / FCF | 17.27 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.95 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 3.07 |
| Debt / FCF | 5.30 |
| Interest Coverage | 5.79 |
Financial Efficiency
Return on equity (ROE) is 9.03% and return on invested capital (ROIC) is 7.69%.
| Return on Equity (ROE) | 9.03% |
| Return on Assets (ROA) | 4.69% |
| Return on Invested Capital (ROIC) | 7.69% |
| Return on Capital Employed (ROCE) | 11.36% |
| Revenue Per Employee | $1.87M |
| Profits Per Employee | $23,995 |
| Employee Count | 65,680 |
| Asset Turnover | 2.45 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $524.00 million in taxes.
| Income Tax | 524.00M |
| Effective Tax Rate | 24.88% |
Stock Price Statistics
The stock price has decreased by -15.77% in the last 52 weeks. The beta is 0.44, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -15.77% |
| 50-Day Moving Average | 263.93 |
| 200-Day Moving Average | 262.26 |
| Relative Strength Index (RSI) | 44.56 |
| Average Volume (20 Days) | 1,705,679 |
Short Selling Information
The latest short interest is 4.63 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 4.63M |
| Short Previous Month | 4.68M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 3.85% |
| Short Ratio (days to cover) | 2.73 |
Income Statement
In the last 12 months, Humana had revenue of $123.11 billion and earned $1.58 billion in profits. Earnings per share was $13.04.
| Revenue | 123.11B |
| Gross Profit | 18.51B |
| Operating Income | 3.77B |
| Pretax Income | n/a |
| Net Income | 1.58B |
| EBITDA | 4.02B |
| EBIT | 3.77B |
| Earnings Per Share (EPS) | $13.04 |
Full Income StatementBalance Sheet
The company has $21.71 billion in cash and $12.92 billion in debt, giving a net cash position of -$8.88 billion or -$73.84 per share.
| Cash & Cash Equivalents | 21.71B |
| Total Debt | 12.92B |
| Net Cash | -8.88B |
| Net Cash Per Share | -$73.84 |
| Equity (Book Value) | 18.30B |
| Book Value Per Share | 151.61 |
| Working Capital | 16.40B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.93 billion and capital expenditures -$493.00 million, giving a free cash flow of $2.44 billion.
| Operating Cash Flow | 2.93B |
| Capital Expenditures | -493.00M |
| Free Cash Flow | 2.44B |
| FCF Per Share | $20.28 |
Full Cash Flow StatementMargins
Gross margin is 15.03%, with operating and profit margins of 3.06% and 1.28%.
| Gross Margin | 15.03% |
| Operating Margin | 3.06% |
| Pretax Margin | 1.71% |
| Profit Margin | 1.28% |
| EBITDA Margin | 3.26% |
| EBIT Margin | 3.06% |
| FCF Margin | 1.98% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.28%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 27.15% |
| Buyback Yield | 1.21% |
| Shareholder Yield | 2.49% |
| Earnings Yield | 4.74% |
| FCF Yield | 7.34% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $287.67, which is 4.06% higher than the current price. The consensus rating is "Hold".
| Price Target | $287.67 |
| Price Target Difference | 4.06% |
| Analyst Consensus | Hold |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 7.97% |
| EPS Growth Forecast (5Y) | 28.68% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
